Skip to main content
Watch Insiders
MLPTSector not reported

MapLight Therapeutics, Inc. (MLPT) Insider Trading

In the last 90 days, 1 MapLight Therapeutics, Inc. (MLPT) insider reported 1 open-market purchase totaling $50,072,000 and no sales. The most recent open-market purchase was reported on Aug 14, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$50,072,000
Corporate buyers
1
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026Catalyst4 Inc.10% OwnerOpen Market Purchase4,400,000$11.38$50,072,000
Jul 30, 2026Catalyst4 Inc.10% OwnerOpen Market Purchase1,209,225$12.67$15,314,835

Common questions

MLPT insider trading FAQ

Are MLPT insiders buying or selling?
Over the last 90 days, MLPT insiders were net buyers, reporting $50,072,000 of open-market purchases and $0.00 of sales.
When was the last MLPT insider purchase?
The most recent open-market purchase of MapLight Therapeutics, Inc. stock by an insider was reported on Aug 14, 2026, one of 1 purchase in the last 90 days.
Where does MLPT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that MapLight Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.